蟾酥注射液预防肺癌手术后感染临床观察

Clinical Observation of Chansu Injection for Preventing Anti-Infection After Lung Cancer Surgery

目的探讨蟾酥注射液预防肺癌手术患者术后感染的临床疗效。方法选择2014年2月至2016年12月医院收治的肺癌手术患者120例,按随机数字表法分为基础组和治疗组,各60例,基础组患者术后实施常规抗感染治疗,治疗组患者在基础组基础上加用蟾酥注射液治疗。结果治疗组患者治疗后发热、肺部感染发生率为26.67%,明显低于基础组的71.67%(P<0.05);两组术后1 d C反应蛋白、白细胞计数水平对比无明显差异(P>0.05);治疗组术后3,7 d C反应蛋白、白细胞计数水平与基础组相比明显较低(P<0.05);治疗组住院时间与基础组相比明显较短(P<0.05)。结论蟾酥注射液治疗可有效预防肺癌手术患者术后感染。

Objective To investigate the clinical effect of Chansu Injection for preventing anti-infection after lung cancer surgery. Methods Totally 120 patients with lung cancer from February 2014 to February 2017 in our hospital were randomly divided into the basal group and the treatment group, 60 cases in each group. The basal group was given routine anti-infection treatment, on this basis, the treatment group was given Chansu Injection treatment. Results After treatment, the incidence rate of fever and pulmonary infection in the treatment group was 26. 67%, which significantly lower than 71. 67% in the basal group （ P 〈 0. 05 ） . 1 d after surgery, there was no significant difference in the levels of CRP and WBC between the two groups （ P 〉 0. 05 ） , 3, 7 d after surgery, the levels of CRP and WBC in the treatment group were significantly lower than those in the basal group （ P 〈 0. 05 ） . The hospitalization time of the treatment group was significantly shorter than that of the basal group （ P 〈 0. 05 ） . Conclusion Chansu Injection can effectively prevent anti-infection after lung cancer surgery.